In the culmination of a 33-year quest, scientists are reporting a milestone in type 1 diabetes: the first time the disease has been markedly delayed in young people at high risk. According to Science Magazine, California researchers found that 2 weeks of an experimental intravenous drug held off disease by an average of about two years. The mainstay of type 1 diabetes treatment is insulin, discovered 97 years ago. Researcher Jeffrey Bluestone said, "On the one hand,” the outcome is “pretty exciting." But "on the other hand, now the real hard work begins.” That will mean considering how to move the treatment forward and determining whom it’s most likely to help.

Up to 50% Off Men''s Apparel and Outwear at! While Supplies Last!

More videos

Associated Press 11 May 2020 11:44 CEST

AP Top Stories May 11 A